Suchergebnisse - "Alfonso, Pilar Garcia"

PubPharm (15)

1

Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study

enthalten in: BMC cancer | 2024

von Elez, E. | Cubillo, A. | Alfonso, P. | +6

2

Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study

enthalten in: BMC cancer | 2024

von Elez, E. | Cubillo, A. | Alfonso, P. | +6

3

Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients : REFRAME Molecular Study

enthalten in: Cancers | 2021

von Conde, E. | Earl, J. | Crespo-Toro, L. | +15

4

Optimal duration of first-line chemotherapy for advanced gastric cancer : data from the AGAMENON registry

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2020

von Viúdez, A. | Carmona-Bayonas, A. | Gallego, J. | +45

5

Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Hill, A. | Findlay, M. | Burge, M. | +18

6

Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer

enthalten in: Molecular cancer therapeutics | 2017

von Santos, C. | Azuara, D. | Garcia-Carbonero, R. | +19

7

Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastases

enthalten in: Future oncology | 2017

von Aranda, E. | Aparicio, J. | Bilbao, J. | +6

8

Nab-paclitaxel plus gemcitabine as first-line palliative chemotherapy in a patient with metastatic pancreatic cancer with Eastern Cooperative Oncology Group performance status of 2

enthalten in: Oncology letters | 2016

von Martín, A. | Alfonso, P. | Rupérez, A. | +1

9

O-0025 * RANDOMISED, PHASE 2 STUDY (OLIVIA) OF BEVACIZUMAB PLUS MFOLFOX6 OR FOLFOXIRI IN PATIENTS WITH INITIALLY UNRESECTABLE COLORECTAL CANCER LIVER METASTASES

enthalten in: Annals of oncology | 2013

von Adam, R. | Bridgewater, J. | Chau, I. | +5

10

Treatment recommendations for metastatic colorectal cancer

enthalten in: Revista de oncología | 2011

von Aranda, E. | Abad, A. | Carrato, A. | +7